Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H R Draper

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|October 23, 2021
Pharmacokinetics of high-dose isoniazid in children affected by multidrug-resistant TBJ L Winckler, H S Schaaf, H R Draper, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|January 28, 2022
Treatment outcomes and safety in children with rifampicin-resistant TBE Lopez-Varela, A J Garcia-Prats, J A Seddon, et al.
IJTLD Open|April 14, 2025
Children's preferences among six novel moxifloxacin and linezolid-dispersible tablet formulationsG Hoddinott, H R Draper, N Vanqa, et al.
IJTLD Open|October 15, 2025
Acceptability of 100-mg moxifloxacin in children with rifampicin-resistant TB in three high-burden countriesN Suryavanshi, H R Draper, G Dhumal, et al.
IJTLD Open|August 18, 2025
Acceptability of a clofazimine tablet in children with rifampicin-resistant TB in three high-burden countriesL Viljoen, H R Draper, N T Castillo-Carandang, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|October 23, 2021
Pharmacokinetics of high-dose isoniazid in children affected by multidrug-resistant TBJ L Winckler, H S Schaaf, H R Draper, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|January 28, 2022
Treatment outcomes and safety in children with rifampicin-resistant TBE Lopez-Varela, A J Garcia-Prats, J A Seddon, et al.
IJTLD Open|April 14, 2025
Children's preferences among six novel moxifloxacin and linezolid-dispersible tablet formulationsG Hoddinott, H R Draper, N Vanqa, et al.
IJTLD Open|October 15, 2025
Acceptability of 100-mg moxifloxacin in children with rifampicin-resistant TB in three high-burden countriesN Suryavanshi, H R Draper, G Dhumal, et al.
IJTLD Open|August 18, 2025
Acceptability of a clofazimine tablet in children with rifampicin-resistant TB in three high-burden countriesL Viljoen, H R Draper, N T Castillo-Carandang, et al.
Pageof 2